European Journal of Neurology

Calendar
pp. i-i(1)

Instructions for Authors
pp. ii-iii(2)

EFNS guideline on the treatment of cerebral venous and sinus thrombosis
pp. 553-559(7)
Authors: Einhäupl, K.; Bousser, M.-G.; de Bruijn, S. F. T. M.; Ferro, J. M.; Martinelli, I.; Masuhr, F.; Stam, J.

EFNS guideline on the drug treatment of migraine – report of an EFNS task force
pp. 560-572(13)
Authors: Evers, S.; Áfra, J.; Frese, A.; Goadsby, P. J.; Linde, M.; May, A.; Sándor, P. S.

The association between apolipoprotein E and multiple sclerosis
pp. 573-580(8)
Authors: Pinholt, M.; Frederiksen, J. L.; Christiansen, M.

Stroke incidence and prevalence in Europe: a review of available data
pp. 581-598(18)
Authors: Truelsen, T.; Piechowski-Jóźwiak, B.; Bonita, R.; Mathers, C.; Bogousslavsky, J.; Boysen, G.

Subcortical deficit pattern after brain abscess: a neuropsychological study
pp. 599-603(5)
Authors: Visani, P.; Schmutzhard, E.; Trinka, E.; Pfausler, B.; Benke, T.

Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study
pp. 604-610(7)
Authors: Schimrigk, S.; Brune, N.; Hellwig, K.; Lukas, C.; Bellenberg, B.; Rieks, M.; Hoffmann, V.; Pöhlau, D.; Przuntek, H.

Accuracy of bedside diagnosis versus Allen and Siriraj stroke scores in Turkish patients
pp. 611-615(5)
Authors: Ozeren, A.; Bicakci, S.; Burgut, R.; Sarica, Y.; Bozdemir, H.

Parkinson's disease: the genetics of a heterogeneous disorder
pp. 616-627(12)
Authors: Gosal, D.; Ross, O. A.; Toft, M.

A new de novo Notch3 mutation causing CADASIL
pp. 628-631(4)
Authors: Coto, E.; Menéndez, M.; Navarro, R.; García-Castro, M.; Alvarez, V.

Increased GFAP and S100β but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity
pp. 632-638(7)
Authors: Vos, P. E.; van Gils, M.; Beems, T.; Zimmerman, C.; Verbeek, M. M.

Estrogen receptor α and APOEɛ4 polymorphisms interact to increase risk for sporadic AD in Italian females
pp. 639-644(6)
Authors: Porrello, E.; Monti, M. C.; Sinforiani, E.; Cairati, M.; Guaita, A.; Montomoli, C.; Govoni, S.; Racchi, M.

Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry
pp. 645-654(10)
Authors: Vajda, F. J. E.; Hitchcock, A.; Graham, J.; Solinas, C.; O'Brien, T. J.; Lander, C. M.; Eadie, M. J.

Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese population
pp. 655-658(4)
Authors: Furukawa, Y.; Yoshikawa, H.; Yachie, A.; Yamada, M.

A case of cerebral Whipple's disease initially presenting with isolated focal myoclonus
pp. 659-661(3)
Authors: Henning, S.; Tings, T.; Schmidt, H.; Tergau, F.; Wolf, S.; Scholz, K.; Knauth, M.; Buchner, H.; Gold, R.; Paulus, W.

Guillain–Barré syndrome in Pakistan: similarity of demyelinating and axonal variants
pp. 662-665(4)
Authors: Shafqat, S.; Khealani, B. A.; Awan, F.; Abedin, S. E.

Message for caregivers of dementia with Lewy bodies patients: hallucinations can be pleasurable for your patient. Cope with your embarrassment and empathize
pp. 666-666(1)
Author: Pucci, E.

Triptan responsive hypnic headache?
pp. 666-667(2)
Authors: Schürks, M.; Kastrup, O.; Diener, H.-C.

Hemidystonia as initial manifestation of sporadic Creutzfeldt–Jakob disease
pp. 667-668(2)
Authors: Maltête, D.; Guyant-Maréchal, L.; Gérardin, E.; Laquerrière, A.; Martinaud, O.; Mihout, B.; Hannequin, D.

Treatment of an acute attack of porphyria during pregnancy
pp. 668-669(2)
Authors: Badminton, M. N.; Deybach, J.-C.

Treatment response and electrophysiological criteria in chronic inflammatory demyelinating polyneuropathy
pp. 669-670(2)
Authors: Cocito, D.; Chiò, A.; Tavella, A.; Poglio, F.; Paolasso, I.; Ciaramitaro, P.; Bergamasco, B.; Isoardo, G.

Isolated unilateral abducens palsy in idiopathic intracranial hypertension without papilledema
pp. 670-671(2)
Authors: Quattrone, A.; Bono, F.; Fera, F.; Lavano, A.

Generalized status epilepticus possibly induced by gatifloxacin
pp. 671-672(2)
Authors: Koussa, S. F.; Chahine, S. L. Hage; Samaha, E. I.; Riachi, M. A.